PhaseBio Pharmaceuticals, Inc. SEC Filings https://investors.phasebio.com/ PhaseBio Pharmaceuticals, Inc. SEC Filings en CORRESP: CORRESP https://investors.phasebio.com/sec-filings/sec-filing/corresp/0001193125-18-294801 PHASEBIO PHARMACEUTICALS INC Sun, 03 Oct 2021 04:03:03 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8311 UPLOAD: UPLOAD https://investors.phasebio.com/sec-filings/sec-filing/upload/0000000000-19-006717 PHASEBIO PHARMACEUTICALS INC Sun, 03 Oct 2021 02:00:45 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8306 CORRESP: CORRESP https://investors.phasebio.com/sec-filings/sec-filing/corresp/0001193125-19-101693 PHASEBIO PHARMACEUTICALS INC Sun, 03 Oct 2021 00:19:20 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8301 UPLOAD: UPLOAD https://investors.phasebio.com/sec-filings/sec-filing/upload/0000000000-18-030844 PHASEBIO PHARMACEUTICALS INC Sun, 03 Oct 2021 00:15:50 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8296 CORRESP: CORRESP https://investors.phasebio.com/sec-filings/sec-filing/corresp/0001193125-18-299224 PHASEBIO PHARMACEUTICALS INC Sat, 02 Oct 2021 23:38:14 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8291 DRS/A: mendment to a previously filed DRS https://investors.phasebio.com/sec-filings/sec-filing/drsa/0000950123-18-009475 PHASEBIO PHARMACEUTICALS INC Sat, 02 Oct 2021 19:16:22 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8286 UPLOAD: UPLOAD https://investors.phasebio.com/sec-filings/sec-filing/upload/0000000000-18-026518 PHASEBIO PHARMACEUTICALS INC Sat, 02 Oct 2021 18:49:32 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8281 CORRESP: CORRESP https://investors.phasebio.com/sec-filings/sec-filing/corresp/0001193125-20-002161 PHASEBIO PHARMACEUTICALS INC Sat, 02 Oct 2021 17:31:41 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8276 CORRESP: CORRESP https://investors.phasebio.com/sec-filings/sec-filing/corresp/0001193125-19-102582 PHASEBIO PHARMACEUTICALS INC Sat, 02 Oct 2021 17:10:29 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8271 DRS: Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy https://investors.phasebio.com/sec-filings/sec-filing/drs/0000950123-18-007059 PHASEBIO PHARMACEUTICALS INC Sat, 02 Oct 2021 17:08:35 -0400 PhaseBio Pharmaceuticals, Inc. SEC Filings 8266